BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19818534)

  • 21. Cutaneous polyarteritis nodosa in a patient with Crohn's disease.
    Komatsuda A; Kinoshita K; Togashi M; Maki N; Masai R; Niitsu H; Ohtani S; Sageshima M; Sawada K; Wakui H
    Mod Rheumatol; 2008; 18(6):639-42. PubMed ID: 18712460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous vasculitis in Crohn's disease.
    Limdi JK; Doran HM; Crampton JR
    J Crohns Colitis; 2010 Sep; 4(3):351-2. PubMed ID: 21122529
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythema induratum (nodular vasculitis) associated with Crohn's disease: a rare type of metastatic Crohn's disease.
    Misago N; Narisawa Y
    Am J Dermatopathol; 2012 May; 34(3):325-9. PubMed ID: 22172959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulcerative Pyoderma Gangrenosum and Leukocytoclastic Vasculitis in a Hypothyroid Woman: A Case Report.
    Agarwal US; Agarwal P; Prakash C; Sharma P
    Wounds; 2017 Jun; 29(6):E43-E47. PubMed ID: 28682293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease.
    Bosch X
    Gastroenterology; 1998 May; 114(5):1061-5. PubMed ID: 9558297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
    Costa-Moreira P; Lopes S; Santos AL; Pedrosa AF; Andrade P; Portugal R; Macedo G
    J Crohns Colitis; 2020 Feb; 14(2):274-276. PubMed ID: 31267125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cutaneous symptoms of ulcero-haemorragic rectocolitis and of Crohn's disease (author's transl)].
    Thivolet J; Ortonne JP; Jeune R
    Ann Dermatol Venereol; 1978; 105(8-9):723-7. PubMed ID: 367248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of Crohn's disease.
    Wilkins T; Jarvis K; Patel J
    Am Fam Physician; 2011 Dec; 84(12):1365-75. PubMed ID: 22230271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangrenosum complicating Crohn's disease.
    Korelitz BI; Sommers SC
    Am J Gastroenterol; 1977 Aug; 68(2):171-6. PubMed ID: 920718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG
    Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic Crohn's disease: remission induced by mesalamine and prednisone.
    Gilson MR; Elston LC; Pruitt CA
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):476-9. PubMed ID: 10459127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes.
    Jansen FM; Vavricka SR; den Broeder AA; de Jong EM; Hoentjen F; van Dop WA
    United European Gastroenterol J; 2020 Nov; 8(9):1031-1044. PubMed ID: 32921269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS; Rubin A; Das K
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Avnstrøm S; Vinding KK; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Tighineanu O; Mihu I; Barros LF; Magro F; Lazar D; Goldis A; Fernandez A; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2014 Nov; 8(11):1506-15. PubMed ID: 24998983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association between membranous glomerulonephritis and Crohn's disease].
    Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
    Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocytoclastic Vasculitis in a Patient With Crohn Disease: A Case Report.
    Bugada MD; Emani VK
    J Investig Med High Impact Case Rep; 2023; 11():23247096231181865. PubMed ID: 37357841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localised gastrocnemius myositis in Crohn's disease.
    Christopoulos C; Savva S; Pylarinou S; Diakakis A; Papavassiliou E; Economopoulos P
    Clin Rheumatol; 2003 May; 22(2):143-5. PubMed ID: 12740681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.